Preliminary determination of the association between symptom expression and urinary metabolites in subjects with chronic fatigue syndrome

Biochemical and Molecular Medicine

Volumn 58, Issue 1, 1996, Pages 85-92

  McGregor, Neil R ^a   Dunstan, R Hugh ^b   Zerbes, Mariann ^b   Butt, Henry L ^c   Roberts, Timothy K ^b   Klineberg, Iven J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c JOHN HUNTER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ALANINE;

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENERGY METABOLISM; FEMALE; GENE EXPRESSION; HUMAN; INCIDENCE; MALE; MULTIPLE REGRESSION; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; URINARY EXCRETION;

EID: 0030175751     PISSN: 10773150     EISSN: None     Source Type: Journal    
DOI: 10.1006/bmme.1996.0036     Document Type: Article

References (17)

1. 1. Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: A working case definition. Ann Intern Med 108:387-389, 1988.
2. 2. Sharpe MC, Archard LC, Banatvala JE, et al. A report -Chronic fatigue syndrome: guidelines for research. J R Soc Med 84:118-121, 1991.
3. 3. Lloyd AR, Hickie I, Broughton C, et al. Prevalence of chronic fatigue syndrome in an Australian population. Med J Aust 153:522-528, 1990.
4. 4. Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann Intern Med 121:953-959, 1994.
5. 5. McGregor NR, Dunstan RH, Zerbes M, Butt HL, Roberts TK, Klineberg IJ. Preliminary determination of a molecular basis to chronic fatigue syndrome. Biochem Mol Med 57:73-80, 1996.
6. 6. Ott M, Schmidt J, Young B, Ott L, Kryscio R, McClain C. Nutritional and metabolic variables correlate with amino acid forearm flux in patients with severe head injury. Crit Care Med 22:393-398, 1994.
7. 7. Byrne E, Trounce I, Dennett X. Chronic relapsing myalgia (? post viral): Clinical, histological, and biochemical studies. Aust NZ J Med 15:305-308, 1985.
8. 8. Hyde BM, Goldstein J, Levine P. (Eds.) The clinical and scientific basis of myalgic encephalomyelitis/chronic fatigue syndrome. Ogdensburg, New York: The Nightingale Foundation, 1992.
9. 9. Dunstan RH, Donohoe M, Taylor W, Roberts TK, Murdoch RN, Watkins JA, McGregor NR. A preliminary investigation of chlorinated hydrocarbons and chronic fatigue syndrome. Med J Aus 163:294-297, 1995.
10. 10. Wu FS, Gibbs TT, Farb DH. Dual activation of GABAA and glycine receptors by beta-alanine: Inverse modulation by progesterone and 5-alpha-pregan-3-alpha-ol-20-one. Eur J Pharmacol 246:239-246, 1993.
11. 11. Scriver CR, Nutzenadel W, Perry TL. Disorders of β-alanine and carnosine metabolism. In The Metabolic Basis of Inherited Disease. (Stanbury JB, Wyngaarden JB, and Frederickson DS, Eds.) New York, McGraw-Hill, 1978, 4th ed., pp 528-542.
12. 12. Yadid G, Youdim MB, Zinder O. Uptake and receptor sites for glycine in isolated bovine adrenal medulla chromaffin cells. Neuroscience 55:1147-1152, 1993.
13. 13. Ault B, Hildebrand LM. GABAA receptor-mediated excitation of nociceptive afferents in the rat isolated spinal cord-tail preparation. Neuropharmacology 33(1):109-114, 1994.
14. 14. Suhadolnik RJ, Reichenbach NL, Hitzges P, et al. Upregulation of the 2-5A Synthetase/RNase L pathway associated with chronic fatigue syndrome. Clin Infect Dis 18:S96-S104, 1994.
15. 15. Coderre TJ. The role of excitatory amino acid receptors and intracellular messengers in persistent nociception after tissue injury in rats. Mol Neurobiol 7:229-246, 1993.
16. 16. Nasstrom J, Karlsson U, Post C. Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice. Eur J Pharmacol 212:(1)21-29, 1992.
17. 17. Jedema HP, Moghaddam B. Glutamatergic control of dopamine release during stress in the rat prefrontal cortex. J Neurochem 63(2):785-788, 1994.